Bir AMATEM Kliniğinin 2019 ve 2020 Yılı Yatan Hasta Verilerinin Karşılaştırması

Öz

Amaç: Bu çalışmanın amacı, koronavirüs hastalığı 2019 (COVID-19) pendemisinin, bir ruh sağlığı hastanesinin AMATEM kliniğine yatırılan hastalar arasında hastaneye yatış oranları ve madde kullanım örüntüleri üzerindeki etkisini, 2020 yılına ait verileri pandemic öncesi 2019 yılı verileriyle karşılaştırarak incelemektir. Gereç ve Yöntem: Elazığ Ruh Sağlığı ve Hastalıkları Hastanesi’nin AMATEM kliniğine 01.07.2019-31.12.2019 ve 01.07.2020-31.12.2020 tarihleri arasında yatışı gerçekleştirilmiş bütün hastalar çalışmaya dâhil edilmiştir. Hastalara ait yaş, tanı, ortalama yatış süreleri, idrar toksikolojisi gibi sosyodemografik ve klinik veriler kaydedilmiştir. Bulgular: 2019 yılında belirtilen tarihlerde 257 yatış, 2020 yılında 126 yatış gerçekleşmişti. En sık saptanan tanı çoklu madde kullanım bozukluğu (n=160), ikinci en sık tanı opioid kullanım bozukluğu (n=111), üçüncü en sık tanı alkol kullanım bozukluğu (n=56) idi. En sık çoklu madde kombinasyonu metamfetamin+opioid (n=47) ve metamfetamin+esrar (n=32) idi. Metamfetamin+esrar kullanımı olan hastalarda ortalama yaş metamfetamin+opioid kullananlara göre daha yüksekken (p=0.023), ortalama yatış süresi metamfetamin+esrarda daha düşüktü (p=0.008). Sonuç: COVİD-19 pandemisi bir ruh sağlığı hastanesinin AMATEM kliniğindeki hospitalizasyon sayılarının azalmasına ek olarak yaygın madde kullanım kombinasyonlarındaki değişiklikleri de içeren madde kullanım özelliklerinin değişmesiyle sonuçlanmıştır. Bu değişimlerin COVID-19 pandemisi döneminde maddeye erişilebilirliğin değişmesiyle ilişkili olduğunu varsaymak makul görünmektedir.

Anahtar Kelimeler

• COVİD-19
• Pandemi
• Yatan hasta
• Madde kullanımı
• Alkol

Comparison of 2019 and 2020 Inpatient Data of an AMATEM Clinic

Öz

Objective: This study aims to examine the impact of the coronavirus disease 2019 (COVID-19) pandemic on hospitalisation rates and substance use patterns among patients admitted to the AMATEM clinic of a mental health hospital, by comparing data from 2020 with pre-pandemic data from 2019. Material and Method: All patients who were admitted to the AMATEM clinic of Elazığ Mental Health and Diseases Hospital between 01.07.2019-31.12.2019 and 01.07.2020-31.12.2020 were included in the study. Sociodemographic and clinical data of the patients, such as age, diagnosis, mean duration of hospitalization, and urine toxicology, were recorded. Results: There were 257 hospitalizations on the dates specified in 2019 and 126 hospitalizations in 2020. The most common diagnosis was multiple substance use disorder (n=160), the second most common diagnosis was opioid use disorder (n=111), and the third most common diagnosis was alcohol use disorder (n=56). The most common multiple substance combinations were methamphetamine+opioid (n=47) and methamphetamine+cannabis (n=32). While the mean age in patients using methamphetamine+cannabis was higher than in patients using methamphetamine+opioid (p=0.023), the mean duration of hospitalization was lower in patients using methamphetamine+cannabis (p=0.008). Conclusion: The COVID-19 pandemic has resulted in decreased hospitalization numbers in a mental health hospital’s AMATEM clinic, as well as changes in substance use patterns, including changes in common substance use combinations. It seems reasonable to posit that these shifts were associated with altered substance accessibility during the period of the COVID-19 pandemic.

Anahtar Kelimeler

• COVID-19
• Pandemic
• Inpatient
• Substance use
• Alcohol

Kaynakça

1. Pinilla J, Barber P, Vallejo-Torres L, Rodríguez-Mireles S, López-Valcárcel BG, Serra-Majem L. The Economic Impact of the SARS-COV-2 (COVID-19) Pandemic in Spain. Int J Environ Res Public Health. 2021;18(9):4708. doi: 10.3390/ijerph18094708.
2. Ahmed N, Barnett P, Greenburgh A, Pemovska T, Stefanidou T, Lyons N, et al. Mental health in Europe during the COVID-19 pandemic: a systematic review. Lancet Psychiatry. 2023;10:537-556. doi: 10.1016/S2215-0366(23)00113-X.
3. Murphy L, Markey K, O' Donnell C, Moloney M, Doody O. The impact of the COVID-19 pandemic and its related restrictions on people with pre-existent mental health conditions: A scoping review. Arch Psychiatr Nurs. 2021;35(4):375-394. doi: 10.1016/j.apnu.2021.05.002.
4. Penninx BWJH, Benros ME, Klein RS, Vinkers CH. How COVID-19 shaped mental health: from infection to pandemic effects. Nat Med. 2022;28:2027-2037. doi: 10.1038/s41591-022-02028-2.
5. Thome J, Coogan AN, Simon F, Fischer M, Tucha O, Faltraco F, et al. The impact of the COVID-19 outbreak on the medico-legal and human rights of psychiatric patients. Eur Psychiatry. 2020;63:e50. doi: 10.1192/j.eurpsy.2020.58.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Washington, DC: Author, American Psychiatric Publishing, 2013.
7. Doğan M, Bayraktar M. COVID-19 with a public health perspective: Measures taken in Turkey and public compliance with the measures. Iran J Public Health. 2020;49:67-75.
8. Bulut M, Savaş HA, Cansel N, Selek S, Kap Ö, Yumur M, Vırıt O. Gaziantep Üniversitesi alkol ve madde kullanım bozuklukları birimine başvuran hastaların sosyodemografik özellikleri. Bağımlılık Dergisi. 2006;7:65-70.

9. Karaagac H, Esenkaya Usta Z, Usta A, Gumus Yarmali M, Godekmerdan A. Retrospective analysis of sociodemographic characteristics of inpatients at Kayseri Research and Training Hospital AMATEM Clinic. Dusunen Adam. 2017;30:251-257.
10. Orum MH, Egilmez OB, Kara MZ. Comparison of AMATEM Data of Adiyaman Province for 2017-2018 and Determination of Alcohol-Drug Orientation. Psychiatry and Behavioral Sciences. 2019;9:198-200.
11. Egilmez OB, Örüm MH, Kara MZ. Adıyaman ili AMATEM verilerinin geriye dönük olarak incelenmesi: 2018 yılı verileri. Bağımlılık Dergisi. 2019;20(2):88-96.
12. Egilmez OB, Örüm MH, Dumlupınar E. Comparative analysis of the probation implementations in Adıyaman province: The data of 2017 and 2018. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi. 2020;22:30-38.
13. United Nations Office on Drugs and Crime. World Drug Report 2023. United Nations Publication, 2023.
14. Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237. doi: 10.1016/j.drugpo.2021.103237.
15. Fiorentini A, Cantù F, Crisanti C, Cereda G, Oldani L, Brambilla P. Substance-Induced Psychoses: An Updated Literature Review. Front Psychiatry. 2021;12:694863. doi: 10.3389/fpsyt.2021.694863.
16. Niles JK, Gudin J, Radcliff J, Kaufman HW. The Opioid epidemic within the COVID-19 pandemic: Drug testing in 2020. Popul Health Manag. 2021;24(S1):43-51.
17. Orallı LE, Atasever B, Tuzluca ZH, Alptekin D, Özdemir Z. Afghanistan-related drug traffic as a new threat to Turkey and Europe. Middle East Perspectives. 2023;2:52-90.